PAF AND HEMATOPOIESIS .3. PRESENCE AND METABOLISM OF PLATELET-ACTIVATING-FACTOR IN HUMAN BONE-MARROW

被引:32
作者
DENIZOT, Y
TRIMOREAU, F
DUPUIS, F
VERGER, C
PRALORAN, V
机构
[1] Laboratoire d'Hématologie Expérimentale, Faculté de Médecine, 87025 Limoges
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1995年 / 1265卷 / 01期
关键词
PLATELET-ACTIVATING FACTOR; BONE MARROW; HEMATOPOIESIS; (HUMAN);
D O I
10.1016/0167-4889(94)00193-I
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Platelet-activating factor (PAF) is a phospholipid compound with major immunoregulatory activities. The present study shows that human bone marrow contains 576 +/- 39 pg PAF/ml (n = 35). Bone marrow-derived PAF exhibits the same biophysical and biological properties that synthetic PAF. PAF concentrations in bone marrow are correlated with the granulocyte (r = 0.4, P = 0.02) but not with the lymphocyte (r = 0.24, P = 0.17) and the monocyte(r = 0.12, P = 0.48) counts. In bone marrow PAF is inactivated by a plasma PAF acetylhydrolase activity (48.0 +/- 2.3 nmol/min per mi, n = 34). Experiments with [H-3]PAF indicate that human bone marrow cells actively metabolize this potent molecule by the deacetylation-transacylation pathway. Results of this investigation indicate the permanent presence of significant amounts of PAF in bone marrow suggesting its putative involvement in the processes of bone marrow cell proliferation and maturation.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 42 条
[1]   INTERACTION OF PLATELET-ACTIVATING FACTOR WITH INTERFERON-GAMMA IN THE STIMULATION OF INTERLEUKIN-1 PRODUCTION BY HUMAN MONOCYTES [J].
BARTHELSON, R ;
VALONE, F .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 86 (02) :193-201
[2]   STRUCTURAL-ANALYSIS OF PURIFIED PLATELET-ACTIVATING FACTOR BY LIPASES [J].
BENVENISTE, J ;
LECOUEDIC, JP ;
POLONSKY, J ;
TENCE, M .
NATURE, 1977, 269 (5624) :170-171
[3]   METABOLISM OF PLATELET-ACTIVATING-FACTOR (1-ALKYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE) AND 1-ALKYL-2-ACETYL-SN-GLYCEROL BY HUMAN-ENDOTHELIAL CELLS [J].
BLANK, ML ;
SPECTOR, AA ;
KADUCE, TL ;
LEE, TC ;
SNYDER, F .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 876 (03) :373-378
[4]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[5]  
BOSSANT MJ, 1990, METHOD ENZYMOL, V187, P125
[6]   PLATELET-ACTIVATING-FACTOR AND CELLULAR IMMUNE-RESPONSES [J].
BRAQUET, P ;
ROLAPLESZCZYNSKI, M .
IMMUNOLOGY TODAY, 1987, 8 (11) :345-350
[7]  
CAZENAVE JP, 1979, LAB INVEST, V41, P275
[8]  
COLUMBO M, 1990, J IMMUNOL, V145, P3855
[9]   EFFECTS OF PLATELET-ACTIVATING-FACTOR ON HUMAN T-CELLS AND B-CELLS - AN OVERVIEW [J].
DENIZOT, Y ;
DUPUIS, F ;
PRALORAN, V .
RESEARCH IN IMMUNOLOGY, 1994, 145 (02) :109-116
[10]   PAF AND HEMATOPOIESIS .1. 5-FLUORO-URACIL INDUCES PAF PRODUCTION IN HEMATOPOIETIC ORGANS OF RATS [J].
DENIZOT, Y ;
PRALORAN, V .
MEDIATORS OF INFLAMMATION, 1994, 3 (01) :23-25